R-Pharm
Russian private pharmaceutical company, head office in Moscow, Russia
Nº Q18398598 ★★★
Rare · Organizations
R-Pharm
Russian private pharmaceutical company, head office in Moscow, Russia
R-Pharm (Russian: Р-Фарм) is an international pharmaceutical company headquartered in Russia. It reached the headlines in September 2020 following approval of its drug "Coronavir" as a treatment in cases of mild to moderate COVID-19 infection.
Last price
—
Floor price
—
7-day median
—
30-day sales
0
30-day range
—
In circulation
0
Price history
median
low – high
sales
No sales in this period
Show table
| Date | median | Low | High | sales |
|---|
Sales history
- Last sale
- —
- 30-day average
- —
- 30-day low
- —
- 30-day high
- —
- Sales 7d
- 0
- Sales 30d
- 0
No sales yet.
Anonymous sales: no buyer or seller shown. Figures count player-to-player sales only.
From Wikipedia
R-Pharm (Russian: Р-Фарм) is an international pharmaceutical company headquartered in Russia. It reached the headlines in September 2020 following approval of its drug "Coronavir" as a treatment in cases of mild to moderate COVID-19 infection. It was founded by Alexey Repik (ru) in 2001, but has had an increasingly international operations base since, with Japanese Corporation Mitsui & Co., Ltd. acquiring 10% of its shares in 2017. In 2022, against the background of the introduction of personal sanctions, Alexey Repik resigned from the owners of R-Pharm, selling his share in the company to the management of R-Pharm, and resigned as chairman of the board of directors.
Text: Wikipédia, CC BY-SA 4.0. · Image: Tirdanir (Public domain) ·
